Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $38,864 | $33,974 | $29,067 | $24,127 |
| % Growth | 14.4% | 16.9% | 20.5% | – |
| Cost of Goods Sold | $27,315 | $23,766 | $20,258 | $16,921 |
| Gross Profit | $11,550 | $10,207 | $8,809 | $7,206 |
| % Margin | 29.7% | 30% | 30.3% | 29.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,567 | $1,504 | $1,250 | $912 |
| SG&A Expenses | $9,195 | $8,193 | $7,056 | $5,879 |
| Sales & Mktg Exp. | $7,628 | $6,689 | $5,806 | $4,967 |
| Other Operating Expenses | -$12 | -$66 | $107 | $0 |
| Operating Expenses | $9,183 | $8,127 | $6,975 | $5,832 |
| Operating Income | $2,367 | $2,080 | $1,480 | $1,222 |
| % Margin | 6.1% | 6.1% | 5.1% | 5.1% |
| Other Income/Exp. Net | -$951 | -$864 | -$646 | -$340 |
| Pre-Tax Income | $1,416 | $1,217 | $1,193 | $987 |
| Tax Expense | $207 | $130 | $178 | $223 |
| Net Income | $1,198 | $1,055 | $996 | $752 |
| % Margin | 3.1% | 3.1% | 3.4% | 3.1% |
| EPS | 0.73 | 0.62 | 0.58 | 0.44 |
| % Growth | 17.7% | 6.9% | 31.8% | – |
| EPS Diluted | 0.72 | 0.62 | 0.58 | 0.44 |
| Weighted Avg Shares Out | 1,649 | 1,695 | 1,714 | 1,715 |
| Weighted Avg Shares Out Dil | 1,655 | 1,695 | 1,720 | 1,720 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $46 | $0 | $0 |
| Interest Expense | $813 | $738 | $293 | $228 |
| Depreciation & Amortization | $912 | $798 | $1,473 | $1,292 |
| EBITDA | $3,140 | $2,752 | $2,453 | $2,630 |
| % Margin | 8.1% | 8.1% | 8.4% | 10.9% |